HRTX FY 2018 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$77M+151.8% YoY

Gross Profit

$50M64.5% margin

Operating Income

-$184M-237.4% margin

Net Income

-$179M-230.8% margin

EPS (Diluted)

$-2.44

Cash Flow

Operating Cash Flow

-$192M

Free Cash Flow

-$201M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$462M

Total Liabilities

$92M

Stockholders' Equity

$370M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$77M	$31M	+151.8%
Gross Profit	$50M	$26M	+90.8%
Operating Income	-$184M	-$195M	+5.5%
Net Income	-$179M	-$197M	+9.4%